Literature DB >> 1559301

A novel variant of growth hormone (GH) insufficiency following low dose cranial irradiation.

E C Crowne1, C Moore, W H Wallace, A L Ogilvy-Stuart, G M Addison, P H Morris-Jones, S M Shalet.   

Abstract

OBJECTIVE: We aimed to investigate the effect of low dose (1800 cGy) prophylactic cranial irradiation on physiological growth hormone secretion.
DESIGN: We performed an analysis of 24-hour serum GH profiles using 20-minute sampling. PATIENTS: Forty-four children were studied, of whom 21 were long-term survivors of acute lymphoblastic leukaemia and 23 were normal children. They were further subdivided into prepubertal, pubertal and post-pubertal groups. MEASUREMENTS: GH profiles were analysed by autocorrelation, Fourier transformation and spectral analysis of stationarized data, and peak detection using the Pulsar peak detection program. RESULTS In the normal children, there was a significant increase in the median (range) area under the curve (AUC) of the GH profile between the prepubertal and pubertal groups (62 (11-124) and 137 (142-158) IU/I/h respectively, (P less than 0.01)). There was also a change in the spectral analysis through puberty. The dominant frequencies were spread widely in the prepubertal and post-pubertal groups but sharply focused in the pubertal group. In the cranially irradiated children there was no significant increase in AUC between the prepubertal (62(13-110) IU/I/h) and pubertal groups (92 (14-163) IU/I/h). The wide range of dominant frequencies persisted in the pubertal cranially irradiated group due to the presence of additional high frequency pulses. The impression of a disturbance of the periodicity of GH secretion in the cranially irradiated pubertal group was further supported by the finding that the autocorrelation function in this group alone was not significantly different from that which would arise from random data.
CONCLUSIONS: A novel form of GH insufficiency has been observed after low dose irradiation in childhood in which an abnormality of periodicity and a quantitative reduction in GH secretion appears restricted to puberty.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1559301     DOI: 10.1111/j.1365-2265.1992.tb02903.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  9 in total

1.  Pitfalls in the assessment of body composition in survivors of acute lymphoblastic leukaemia.

Authors:  J T Warner; W D Evans; D K H Webb; J W Gregory
Journal:  Arch Dis Child       Date:  2004-01       Impact factor: 3.791

Review 2.  Pediatric brain tumor treatment: growth consequences and their management.

Authors:  Sogol Mostoufi-Moab; Adda Grimberg
Journal:  Pediatr Endocrinol Rev       Date:  2010-09

Review 3.  Hypopituitarism as a consequence of brain tumours and radiotherapy.

Authors:  Ken H Darzy; Stephen M Shalet
Journal:  Pituitary       Date:  2005       Impact factor: 4.107

4.  Sexually dimorphic and radiation dose dependent effect of cranial irradiation on body mass index.

Authors:  F Craig; A D Leiper; R Stanhope; C Brain; S T Meller; S S Nussey
Journal:  Arch Dis Child       Date:  1999-12       Impact factor: 3.791

Review 5.  Late effects of antineoplastic therapy in childhood on growth and endocrine function.

Authors:  W H Wallace; C J Kelnar
Journal:  Drug Saf       Date:  1996-11       Impact factor: 5.606

Review 6.  Hypopituitarism following radiotherapy.

Authors:  Ken H Darzy; Stephen M Shalet
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

7.  Patterns of obesity in boys and girls after treatment for acute lymphoblastic leukaemia.

Authors:  I Odame; J J Reilly; B E Gibson; M D Donaldson
Journal:  Arch Dis Child       Date:  1994-08       Impact factor: 3.791

8.  Longitudinal growth and final height in long-term survivors of childhood leukaemia.

Authors:  A Cicognani; E Cacciari; P Rosito; A F Mancini; G Carlă; M Mandini; G Paolucci
Journal:  Eur J Pediatr       Date:  1994-10       Impact factor: 3.183

Review 9.  Radiation-induced hypopituitarism after cancer therapy: who, how and when to test.

Authors:  Ken H Darzy
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2009-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.